fashion -WSS

fashion

author：fashion 2025-09-06 02:13:40 - browse：84922

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Psychedelics group wrestles with new pharma identity

WSS

Republicans love RFK Jr. What's that tell us about health in 2024?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Listen: Vivek Ramaswamy's star turn & leaky drug data

Malaria cases in Florida and Texas: Here’s what you need to know

As demand for Covid shots wanes, Moderna seeks its next success

Moonlake's readout produced a cash windfall. Risks remain

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Virginia high school admissions case could be legal follow

Medicare details structure of new drug price negotiation program

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA greenlights medical device to combat bladder issues

The cancer drug shortage isn’t new — and neither are the solutions

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Guidelines to prevent youth baseball injuries need more muscle

Activists slam private health insurers over coverage restrictions

BioMarin wins approval for gene therapy to treat hemophilia A

Psychedelics group wrestles with new pharma identity

Wikipedia

Trans patients at the end of life deserve respect and dignity

New air purifier tech could be key to improving indoor air quality

Study: Spinal cord stimulation helps patients with paralysis walk again

Cancer drug shortages should be causing more outrage

At least 13 dead in Texas as scorching temps continue

How the first Native Hawaiian psychiatrist helped diversify medicine

hotspot

Wikipedia

entertainment

focus